// App-Quantinova.ai

TCT-430 : ABSORB everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in daily clinical practice. A single center registry analysis

Researchers

Presenter

  • Mariella E Hassell

Principal Investigators

  • Robin P Kraak

  • Maik J Grundeken

  • Joanna J Wykrzykowska

  • Karel T Koch

  • Jose P Henriques

  • Jan Baan Jr

  • Marije M Vis

  • Karin Arkenbout

  • Jan G Tijssen

  • Robbert J de Winter

  • Jan Piek

Medical Centers

  • VU Medical Center Amsterdam, Amsterdam, Netherlands

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Locations

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Chronic total occlusion

  • Acute Coronary Syndromes

  • Angina

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved